gold has been researched along with thalidomide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, RE; Lo, JS; Tomecki, KJ | 1 |
| Schrader, KE | 1 |
| Asahi, T; Nakanishi, T; Ohtani, B; Osaka, T; Shibata, N; Yamakawa, N | 1 |
| Bieber, T; Tüting, T; Uerlich, M; Wenzel, J | 1 |
| Feng, F; Han, L; Jiang, X; Liu, F; Liu, W; Sun, H; Wang, Y; Xue, J; Yang, F | 1 |
2 review(s) available for gold and thalidomide
| Article | Year |
|---|---|
Treatment of discoid lupus erythematosus.
Topics: Antimalarials; Dapsone; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Lupus Erythematosus, Discoid; Retinoids; Sunscreening Agents; Thalidomide | 1989 |
[Systemic treatment of cutaneous lupus erythematosus].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antimalarials; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dapsone; Dermatologic Agents; Female; Gold; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Cutaneous; Male; Methotrexate; Plasmapheresis; Pregnancy; Retinoids; Thalidomide; Time Factors | 2003 |
3 other study(ies) available for gold and thalidomide
| Article | Year |
|---|---|
[Damages to the anterior eye segment by drugs].
Topics: Anti-Bacterial Agents; Anticoagulants; Antidepressive Agents; Cornea; Dinitrophenols; Drug-Related Side Effects and Adverse Reactions; Epinephrine; Eye Diseases; Glucocorticoids; Gold; Humans; Hydantoins; Idoxuridine; Keratoconjunctivitis; Miotics; Phenacetin; Phenothiazines; Retinal Detachment; Silver Nitrate; Stevens-Johnson Syndrome; Sulfonamides; Thalidomide; Vision Disorders | 1969 |
Chiral discrimination between thalidomide enantiomers using a solid surface with two-dimensional chirality.
Topics: Carboxylic Acids; Gold; Stereoisomerism; Thalidomide | 2004 |
Targeted degradation of anaplastic lymphoma kinase by gold nanoparticle-based multi-headed proteolysis targeting chimeras.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Cell Proliferation; Cell Survival; Drug Delivery Systems; Drug Screening Assays, Antitumor; Gold; Humans; Metal Nanoparticles; Molecular Structure; Particle Size; Protein Kinase Inhibitors; Proteolysis; Surface Properties; Thalidomide; Tumor Cells, Cultured | 2020 |